ArticleMolecular oncology2021

NGS-based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment.

Estela Sánchez-Herrero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.